Abbott Laboratories
ABTLast close · Oct 16, 2026104.88+0.20 (+0.19%)
Market cap$181.5B
Of the 85 managers this site tracks, 9 held Abbott Laboratories (ABT) at the end of Q3 2026, their latest 13Fs. The largest position by value was Jensen's, $80.3M; Mason Hawkins's ($76.3M) and Mairs & Power's ($66.2M) follow. No Schedule 13D or 13G is on file for ABT from the activists and large holders the site follows.
Superinvestors holding ABT
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Jensen | Jensen Investment Management Inc | Q2 2026 | 885,262 | $80.3M |
| Mason Hawkins | Southeastern Asset Management Inc | Q2 2026 | 840,747 | $76.3M |
| Mairs & Power | Mairs & Power Inc | Q2 2026 | 729,358 | $66.2M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 59,775 | $5.4M |
| David Katz | Matrix Asset Advisors Inc | Q3 2026 | 52,805 | $5.2M |
| Soros | Soros Fund Management LLC | Q2 2026 | 44,750 | $4.1M |
| Dodge & Cox | Dodge & Cox | Q2 2026 | 17,324 | $1.6M |
| Thomas Russo | Gardner Russo & Quinn LLC | Q2 2026 | 11,510 | $1.0M |
| Polen Capital | Polen Capital Management LLC | Q2 2026 | 3,156 | $286,379 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.